Search research articles
Contact Us
Filters
Showing results (351-360 of 520) with videos related to
Page
of 52
Sort By:
Journal of the American College of Cardiology
|
June 3, 2004
Alcohol consumption and prognosis in patients with left ventricular systolic dysfunction after a myocardial infarction
David Aguilar, Hicham Skali, Lemuel A Moyé, et al.
Journal of the American College of Cardiology
|
May 16, 2006
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute
, , , et al.
American Heart Journal
|
July 6, 2010
Fatal myocardial rupture after acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALsartan In Acute myocardial iNfarcTion Trial (VALIANT)
Faisal Shamshad, Satish Kenchaiah, Peter V Finn, et al.
International Journal of Cardiology
|
December 1, 2012
Peripheral artery disease and outcomes after myocardial infarction: an individual-patient meta-analysis of 28,771 patients in CAPRICORN, EPEHESUS, OPTIMAAL and VALIANT
Sally C Inglis, Judith Bebchuk, Sultan A Al-Suhaim, et al.
Journal of the American Heart Association
|
February 8, 2022
Flu Vaccine and Mortality in Hypertension: A Nationwide Cohort Study
Daniel Modin, Brian Claggett, Mads Emil Jørgensen, et al.
American Heart Journal
|
July 11, 2006
Extent of coronary artery disease as a predictor of outcomes in acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both
Rajesh Janardhanan, Satish Kenchaiah, Eric J Velazquez, et al.
Circulation. Heart Failure
|
March 11, 2016
Impact of Spironolactone on Longitudinal Changes in Health-Related Quality of Life in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist Trial
Eldrin F Lewis, Hae-Young Kim, Brian Claggett, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
March 4, 2014
Assessment of myocardial viability and left ventricular function in patients supported by a left ventricular assist device
Deepak K Gupta, Hicham Skali, Jose Rivero, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
September 21, 2016
C-Reactive Protein and Risk of ESRD: Results From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)
Finnian R Mc Causland, Brian Claggett, Emmanuel A Burdmann, et al.
The New England Journal of Medicine
|
September 3, 2009
Cardiac-resynchronization therapy for the prevention of heart-failure events
Arthur J Moss, W Jackson Hall, David S Cannom, et al.
Page
of 52
Search research articles
Search
Showing results (351-360 of 520) with videos related to
Sort By:
Page
of 52
Journal of the American College of Cardiology
|
June 3, 2004
Alcohol consumption and prognosis in patients with left ventricular systolic dysfunction after a myocardial infarction
David Aguilar, Hicham Skali, Lemuel A Moyé, et al.
Journal of the American College of Cardiology
|
May 16, 2006
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute
, , , et al.
American Heart Journal
|
July 6, 2010
Fatal myocardial rupture after acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALsartan In Acute myocardial iNfarcTion Trial (VALIANT)
Faisal Shamshad, Satish Kenchaiah, Peter V Finn, et al.
International Journal of Cardiology
|
December 1, 2012
Peripheral artery disease and outcomes after myocardial infarction: an individual-patient meta-analysis of 28,771 patients in CAPRICORN, EPEHESUS, OPTIMAAL and VALIANT
Sally C Inglis, Judith Bebchuk, Sultan A Al-Suhaim, et al.
Journal of the American Heart Association
|
February 8, 2022
Flu Vaccine and Mortality in Hypertension: A Nationwide Cohort Study
Daniel Modin, Brian Claggett, Mads Emil Jørgensen, et al.
American Heart Journal
|
July 11, 2006
Extent of coronary artery disease as a predictor of outcomes in acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both
Rajesh Janardhanan, Satish Kenchaiah, Eric J Velazquez, et al.
Circulation. Heart Failure
|
March 11, 2016
Impact of Spironolactone on Longitudinal Changes in Health-Related Quality of Life in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist Trial
Eldrin F Lewis, Hae-Young Kim, Brian Claggett, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
March 4, 2014
Assessment of myocardial viability and left ventricular function in patients supported by a left ventricular assist device
Deepak K Gupta, Hicham Skali, Jose Rivero, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
September 21, 2016
C-Reactive Protein and Risk of ESRD: Results From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)
Finnian R Mc Causland, Brian Claggett, Emmanuel A Burdmann, et al.
The New England Journal of Medicine
|
September 3, 2009
Cardiac-resynchronization therapy for the prevention of heart-failure events
Arthur J Moss, W Jackson Hall, David S Cannom, et al.
Page
of 52